Published in Arch Intern Med on November 22, 2004
Rate and predictors of treatment prescription for hepatitis C. Gut (2006) 2.31
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med (2015) 2.17
Hepatitis C treatment completion rates in routine clinical care. Liver Int (2009) 2.10
Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis (2009) 2.10
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf (2011) 1.76
Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS (2009) 1.64
The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62
Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. Am J Kidney Dis (2008) 1.25
Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol (2009) 1.22
Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist (2011) 1.14
Current management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2014) 1.10
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol (2008) 1.08
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS (2009) 1.04
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis (2011) 1.04
Serious Non-AIDS events: Immunopathogenesis and interventional strategies. AIDS Res Ther (2013) 1.01
Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol (2015) 0.96
The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer (2012) 0.93
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PLoS One (2011) 0.89
A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans. AIDS Res Hum Retroviruses (2011) 0.88
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. Br J Cancer (2006) 0.86
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. Clin Gastroenterol Hepatol (2012) 0.86
Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma. J Viral Hepat (2009) 0.85
Substance abuse, HIV-1 and hepatitis. Curr HIV Res (2012) 0.85
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. Can J Infect Dis Med Microbiol (2013) 0.84
Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon (2012) 0.83
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis (2008) 0.83
Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol (2010) 0.82
Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report. Oncologist (2010) 0.81
PPAR and liver injury in HIV-infected patients. PPAR Res (2009) 0.80
Liver transplantation trends in the HIV population. Dig Dis Sci (2011) 0.79
HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
Cancer prevention in HIV-infected populations. Semin Oncol (2015) 0.77
Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand: Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors. Hepat Mon (2011) 0.77
Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus. World J Hepatol (2013) 0.76
The role of viral co-infection in HIV-associated non-AIDS-related cancers. Curr HIV/AIDS Rep (2015) 0.76
Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report. AIDS Patient Care STDS (2010) 0.75
Significance of blood analysis in hemophiliacs co-infected with human immunodeficiency virus and hepatitis viruses. World J Gastroenterol (2007) 0.75
Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report. Infect Agent Cancer (2012) 0.75
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Esophageal carcinoma. N Engl J Med (2014) 5.77
The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol (2005) 4.96
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol (2004) 4.39
Hospital use and survival among Veterans Affairs beneficiaries. N Engl J Med (2003) 4.13
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Obesity: a challenge to esophagogastric junction integrity. Gastroenterology (2006) 3.72
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med (2005) 3.57
The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med (2006) 3.44
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr (2005) 3.37
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
Risk factors for cholangiocarcinoma. Hepatology (2011) 3.27
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol (2013) 3.12
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol (2011) 2.96
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87
Racial differences in doctors' information-giving and patients' participation. Cancer (2006) 2.85
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci (2014) 2.77
Death of an Arabian Jew. Arch Intern Med (2004) 2.73
Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol (2007) 2.73
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol (2006) 2.67
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol (2009) 2.60
Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol (2005) 2.60
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest (2005) 2.59
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology (2011) 2.42
Obesity increases oesophageal acid exposure. Gut (2006) 2.42
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25
The epidemiology of obesity. Gastroenterol Clin North Am (2010) 2.23
Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol (2004) 2.21
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Ethnic variation in knee replacement: patient preferences or uninformed disparity? Arch Intern Med (2005) 2.05
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut (2011) 1.98
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol (2007) 1.96
Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol (2003) 1.91
Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc (2007) 1.89
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology (2011) 1.81
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology (2010) 1.80
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol (2013) 1.80
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol (2008) 1.78
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev (2006) 1.76
The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter (2012) 1.74
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol (2005) 1.72
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol (2006) 1.72
Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol (2002) 1.72
The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology (2012) 1.71
Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol (2003) 1.70
Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol (2004) 1.69
Racial/ethnic differences in preferences for total knee replacement surgery. J Clin Epidemiol (2006) 1.68
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68
Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol (2003) 1.68
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol (2002) 1.66
Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Am J Gastroenterol (2008) 1.64
The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol (2004) 1.62
Association of psychiatric disorders and sleep apnea in a large cohort. Sleep (2005) 1.62
Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61
The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc (2006) 1.60
Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci (2010) 1.57
Hepatocellular carcinoma associated with autoimmune hepatitis. J Clin Gastroenterol (2003) 1.56
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis (2011) 1.53
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology (2010) 1.51
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol (2005) 1.50
A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia. Am J Gastroenterol (2002) 1.47
The effects of flexible bronchoscopy on mechanical ventilation in a pediatric lung model. Chest (2008) 1.47
Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology (2002) 1.47
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology (2014) 1.46
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol (2005) 1.44
Anthropometric correlates of intragastric pressure. Scand J Gastroenterol (2006) 1.43
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41